Pfizer and Allergan to Combine
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Pfizer (PFE) And Allergan (AGN) Could Trade 'Range-Bound', Says Deutsche Bank
November 23, 2015 1:57 PM ESTShares of Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) could be 'range-bound' for some time, according to Deutsche Bank analyst Gregg Gilbert. Comments follow news the two companies reached a $160 billion merger agreement.
"Conceptually, we could see both stocks remaining range-bound for some time (close expected in 2H16) as investors of various types consider the merits of the transaction," said Gilbert."This deal, if closed, will make PFE an... More
